Chatham Rock Phosphate Limited

As of December 31, 2025, Chatham Rock Phosphate Limited carries a market capitalization of 4.62M, placing it among publicly traded companies globally. Its enterprise value stands at 4.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Chatham Rock Phosphate Limited has 115.41M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Chatham Rock Phosphate Limited maintains a current ratio of 0.31, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended December 31, 2025, Chatham Rock Phosphate Limited posted a negative return on equity (ROE) of -14.15, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.28, reflecting losses generated across the asset base.

As of the close on July 30, 2026, Chatham Rock Phosphate Limited's stock has declined approximately 44.44% over the past 52 weeks. The 50-day moving average sits at 0.05, while the 200-day moving average is 0.06.

Over the twelve months ended December 31, 2025, Chatham Rock Phosphate Limited generated - - in revenue and converted that into -902,010.00 in net income, yielding earnings per share of -0.01. EBITDA reached -969,714.00, while operating income came in at -969,714.00.

These figures are as of December 31, 2025. Total book value stands at 6.24M, with working capital of -364,985.00 providing operational flexibility.

These figures cover the twelve months ended December 31, 2025.

These figures cover the twelve months ended December 31, 2025. Total shareholder yield is negative at -11.81, meaning Chatham Rock Phosphate Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Chatham Rock Phosphate Limited's most recent stock split took place on November 3, 2017 with a 500:527 split ratio.

As of December 31, 2025, Chatham Rock Phosphate Limited has an Altman Z-Score of -2.96, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.